Please login to the form below

Not currently logged in
Email:
Password:

NICE gives partial backing to Ferring's prostate cancer drug

National Institute for Health and Care Excellence NICE logo

Firmagon on course for use on NHS in England and Wales

BioAlliance and Topotarget merge to focus on rare cancers

BioAlliance TopotargetFrench and Danish firms combine to develop orphan oncology drugs

Sanofi takes to Twitter to support Spanish pharmacy portal

Says new account on the social network will help support community pharmacists

Menarini launches urology campaign in Greece

Menarini Greece premature ejaculation disease awarenessPE information push includes Not Just A Moment website

GSK gets OK in US for diabetes drug albiglutide

GSK - logo on buildingOnce-weekly Tanzeum will compete against Victoza and Byetta after FDA approval

Boehringer plans to open trial data back to 1998

Boehringer Ingelheim headquartersWill partner with Sanofi, GSK, Roche, Novartis and ViiV Healthcare on online platform

Merck gets US green light for allergy immunotherapy

FDA headquarters White OakExpected to provide a significant boost to company's partner Alk-Abello

BMS files fixed-dose HIV combination in US

Bristol-Myers Squibb (BMS) buildingCombines Reyataz with Gilead Sciences' cobicistat

This month in 1917: A tale of two Mercks

US enters World War I severing ties between Merck & Co and its German parent

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

England’s clinical commissioning landscape
Who are the real masters in the new NHS?...
How will the new landscape of Hep C treatments affect patients?
The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....
Pharma deal watch - handshake
Pharma deals during March 2014
Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month...